EQ Resources Limited reported a record quarterly tungsten concentrate production of 33,249 mtu, driven by operational excellence at its Saloro mine and strategic acquisitions including Tungsten Metals Group Ltd. Despite challenges at Mt Carbine due to low rainfall, the company secured significant funding and is poised for growth.
Pacific Edge announces a two-month delay in the Medicare Local Coverage Determination for its genetic oncology tests, extending the effective date to April 24, 2025. This extension follows the company’s active engagement with US regulatory bodies.